Myovant Sciences Ltd (MYOV)
BMG637AM1024 - Common Stock
ChartMill assigns a Buy % Consensus number of 76% to MYOV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.54. This target is 2.08% above the current price.
MYOV was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about MYOV.
In the previous month the buy percentage consensus was at a similar level.
MYOV was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-10-26 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2022-10-25 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-10-24 | Baird | Downgrade | Outperform -> Neutral |
| 2022-08-09 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2022-07-28 | Goldman Sachs | Maintains | Neutral |
| 2022-05-11 | Goldman Sachs | Maintains | Neutral |
| 2022-04-13 | SVB Leerink | Maintains | Market Perform |
| 2022-02-16 | SVB Leerink | Maintains | Market Perform |
| 2022-01-05 | SVB Leerink | Maintains | Market Perform |
| 2021-10-27 | SVB Leerink | Maintains | Market Perform |
| 2021-09-09 | SVB Leerink | Initiate | Market Perform |
| 2021-02-12 | SVB Leerink | Maintains | Market Perform |